Launch week offerEnds in00h00m00s

annual Promonthly Pro

Haruna Kawano

Associate Professor

Juntendo University

Japan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Japan Professors in Pharmacy Pharmacy professors in Japan

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (15)

Hidetaka Eguchi

Senior Associate Professor

Juntendo University

JAPAN

View details

Takahiro Osawa

Niigata University

JAPAN

View details

YAN LU

Juntendo University

JAPAN

View details

Giovambattista Capasso

Chief Department

Università degli Studi della Campania Luigi Vanvitelli

ITALY

View details

Tomoki Kimura

Juntendo University Hospital

JAPAN

View details

Hiroyuki Yamada

講師 / Senior Lecturer/ Junior Associate Professor

Kyoto University

JAPAN

View details

Wataru Shimabukuro

University of the Ryukyus

JAPAN

View details

Maria Vanessa Perez-Gomez

Hospital Universitario Fundación Jiménez Díaz

SPAIN

View details

Yasushi Okazaki

Professor, Director

Juntendo University

JAPAN

View details

Shuji Isotani

Associate professor

Juntendo University Hospital

JAPAN

View details

Shoichi Maruyama

Professor

Nagoya University Graduate School of Medicine

JAPAN

View details

Jan Halbritter

Chief/Professor

University Medical Center Freiburg

GERMANY

View details

Yosuke Shimada

Juntendo University

JAPAN

View details

Daniel G Fuster

Full Professor (Ordinarius)

University of Bern

SWITZERLAND

View details

Osasuyi Iyasere

Honorary Senior Lecturer

University of Leicester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Haruna Kawano

Research Interests

Make your next move.

Explore related searches

Articles (16)

Local radiotherapy for cancer patients is associated with mosaic loss of chromosome Y, a hallmark of male aging

Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A consensus statement of the ERA Genes & Kidney Working Group

Development and validation of a simplified CT volumetry for estimating total liver volume in patients with autosomal dominant polycystic kidney and liver disease.

Kidney Function Trajectories with Tolvaptan in ADPKD Patients with CKD-G5.

Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy

SUrvey of renal Biopsy registry database and Anticancer dRUg therapy in Japan (SUBARU-J study)

Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP)

Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease

PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease

Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases

Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.

Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease

Retrospective observational study of a novel smartphone app on the management of patients with mild cognitive impairment or mild dementia.

Urine spermine and multiparametric magnetic resonance imaging for prediction of prostate cancer in Japanese men.

High prevalence of frailty in patients with lower urinary tract symptoms.

Clinical Practice Guidelines for tuberous sclerosis complex-associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update.

Collaborators (15)

Hidetaka Eguchi

Takahiro Osawa

YAN LU

Giovambattista Capasso

Tomoki Kimura

Hiroyuki Yamada

Wataru Shimabukuro

Maria Vanessa Perez-Gomez

Yasushi Okazaki

Shuji Isotani

Shoichi Maruyama

Jan Halbritter

Yosuke Shimada

Daniel G Fuster

Osasuyi Iyasere

Make your next move.

Haruna Kawano

Research Interests

Make your next move.

Explore related searches

Articles (16)

Local radiotherapy for cancer patients is associated with mosaic loss of chromosome Y, a hallmark of male aging

Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A consensus statement of the ERA Genes &amp; Kidney Working Group

Development and validation of a simplified CT volumetry for estimating total liver volume in patients with autosomal dominant polycystic kidney and liver disease.

Kidney Function Trajectories with Tolvaptan in ADPKD Patients with CKD-G5.

Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy

SUrvey of renal Biopsy registry database and Anticancer dRUg therapy in Japan (SUBARU-J study)

Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP)

Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease

PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease

Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases

Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.

Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease

Retrospective observational study of a novel smartphone app on the management of patients with mild cognitive impairment or mild dementia.

Urine spermine and multiparametric magnetic resonance imaging for prediction of prostate cancer in Japanese men.

High prevalence of frailty in patients with lower urinary tract symptoms.

Clinical Practice Guidelines for tuberous sclerosis complex-associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update.

Collaborators (15)

Hidetaka Eguchi

Takahiro Osawa

YAN LU

Giovambattista Capasso

Tomoki Kimura

Hiroyuki Yamada

Wataru Shimabukuro

Maria Vanessa Perez-Gomez

Yasushi Okazaki

Shuji Isotani

Shoichi Maruyama

Jan Halbritter

Yosuke Shimada

Daniel G Fuster

Osasuyi Iyasere

Make your next move.

Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A consensus statement of the ERA Genes & Kidney Working Group